comparemela.com

Latest Breaking News On - Gwk investment management - Page 8 : comparemela.com

27,528 Shares in Fiserv, Inc (NYSE:FI) Purchased by Fiduciary Trust Co

Fiduciary Trust Co acquired a new stake in shares of Fiserv, Inc. (NYSE:FI – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,528 shares of the business services provider’s stock, valued at approximately $3,657,000. Several other institutional investors have also […]

Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) is Connable Office Inc s 2nd Largest Position

Connable Office Inc. raised its position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 1.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,154,833 shares of the company’s stock after acquiring an additional 21,466 shares during the period. Vanguard FTSE Developed Markets ETF makes […]

Millrace Asset Group Inc Acquires New Stake in Globus Medical, Inc (NYSE:GMED)

Millrace Asset Group Inc. acquired a new stake in Globus Medical, Inc. (NYSE:GMED – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 39,457 shares of the medical device company’s stock, valued at approximately $2,103,000. Globus Medical accounts for 2.1% […]

Analysts Set Tandem Diabetes Care, Inc (NASDAQ:TNDM) Price Target at $43 80

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average […]

Tandem Diabetes Care, Inc (NASDAQ:TNDM) Given Average Rating of Moderate Buy by Brokerages

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) have earned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.